Skip to content

Parathyroid hormone

Natpara, Natpar (parathyroid hormone) is a protein pharmaceutical. Parathyroid hormone was first approved as Natpara on 2015-01-23. It is used to treat hypocalcemia and hypoparathyroidism in the USA. It has been approved in Europe to treat hypoparathyroidism. It is known to target prolactin-releasing peptide receptor, parathyroid hormone 2 receptor, and parathyroid hormone/parathyroid hormone-related peptide receptor.
Trade Name Natpar
Common Name Parathyroid hormone
Indication hypocalcemia, hypoparathyroidism
Drug Class
Parathyroid hormone
Get full access now